Ribonucleotide Reductase (RR) is a rate-limiting enzyme in DNA synthesis and repair consisting of two subunits, M1 and M2. RRM2 plays a role in cell proliferation, tumorgenicity, metastasis and drug resistance. To better understand the regulation of RRM2, we have sequenced the entire human RRM2 gene. Approximately 10.3 kb of genomic DNA was sequenced and deposited to GenBank (accession number AY032750). Intron/exon junctions were identified and the gene was found to consist of ten exons. Two transcription initiation sites were identified and correspond to mRNA transcripts of 3.4 kb and 1.65 kb. Deletion analysis of the 5′-flanking region showed that there was promoter activity consistent with the presence of two separate promoters driving expression of the two RRM2 transcripts. A thorough analysis of the genomic sequence and promoter regions of the RRM2 gene will provide insight into the processes involved in tumor transformation and drug resistance.   

1.
Albert DA, Nodzenski E, Yim G, Kowalski J: Effect of cyclic AMP on the cell cycle regulation of ribonucleotide reductase M2 subunit messenger RNA concentrations in wild-type and mutant S49 T lymphoma cells. J Cell Physiol 143:251–256 (1990).
2.
Albert DA, Rozengurt E: Synergistic and coordinate subunits in Swill 3T3 cells: effect of multiple signal-transduction pathways. Proc natl Acad Sci, USA 8:1597–1601 (1992).
3.
Ali MA, McWeeney D, Milosavljevic A, Jurka J, Jariwalla RJ: Enhanced malignant transformation induced by expression of a distinct protein domain of ribonucleotide reductase large subunit from herpes simplex virus type 2. Proc natl Acad Sci, USA 88:8257–8261 (1991).
4.
Amara FM, Chen FY, Wright JA: Phorbol ester modulation of a novel cytoplasmic protein binding activity at the 3′-untranslated region of mammalian ribonucleotide reductase R2 mRNA and role in message stability. J biol Chem 269:6709–6715 (1994).
5.
Amara FM, Hurta R, Huang A, Wright J: Altered regulation of message stability and tumor promoter-responsive cis-trans interactions of ribonucleotide reductase R1 and R2 messenger RNAs in hydroxyurea-resistant cells. Cancer Res 5:4503–4506 (1995).
6.
Ayoubi TAY, Van De Ven WJM: Regulation of gene expression by alternative promoters. FASEB J 10:453–460 (1996).
7.
Björklund S, Hjortsberg K, Johansson E, Thelander L: Structure and promoter characterization of the gene encoding the large subunit (R1 protein) of mouse ribonucleotide reductase. Proc natl Acad Sci, USA 90:11322–11326 (1993).
8.
Björklund S, Skog S, Tribukati B, Thelander L: S-phase-specific expression of mammalian ribonucleotide reductase R1 and R2 subunit mRNAs. Biochemistry 29:5452–5458 (1990).
9.
Björklund S, Skogman E, Thelander L: An S-phase specific release from a transcriptional block regulates the expression of mouse ribonucleotide reductase R2 subunit. EMBO J 11:4953–4959 (1992).
10.
Chang CH, Cheng YC: Substrate specificity of human ribonucleotide reductase from Molt-4F cells. Cancer Res 39:5081–5086 (1979).
11.
Chen FY, Amara FM, Wright JA: Mammalian ribonucleotide reductase R1 mRNA stability under normal and phorbol ester stimulating conditions: involvement of a cis-trans interaction at the 3′-untranslated region. EMBO J 12:3977–3986 (1993).
12.
Chen FY, Amara FM, Wright JA: Regulation of mammalian ribonucleotide reductase R1 mRNA stability is mediated by a ribonucleotide reductase R1 mRNA 3′-untranslated region cis-trans interaction through a protein kinase C-condition pathway. Biochem J 302:125–132 (1994).
13.
Choy BK, McClarty GA, Wright JA: Transient elevation of ribonucleotide reductase activity M2 mRNA protein in BALA/c 3T3 fibroblasts in the presence of 12-O-tetradecanoylphorbol-13-acetate. Biochem biophys Res Commun 162:1417–1424 (1989).
14.
Cory JG, Sato A: Regulation of ribonucleotide reductase activity in mammalian cells. Mol Cell Biochem 53:257–266 (1983).
15.
Desai P, Ramakrishnan R, Lin ZW, Osak B, Glorioso JC, Levine M: The RR1gene of herpes simplex virus type 1 is uniquely transactivated by ICPO during infection. J Virol 6:6125–6135 (1993).
16.
Elledge SJ, Davis RW: DNA-damage induction of ribonucleotide reductase. Mol Cell Biol 9:4932–4940 (1989).
17.
Engstrom Y, Eriksson S, Jildevik I, Skog SI, Thelander L, Tribukait B: Cell cycle-dependent expression of mammalian ribonucleotide reductase. Differential regulation of the two subunits. J biol Chem 260:9114–9116 (1985).
18.
Filatov D, Björklund S, Johansson E, Thelander L: Induction of the mouse ribonucleotide reductase R1 and R2 genes in response to DNA damage by UV light. J biol Chem 271:23698–23704 (1996).
19.
Filatov D, Thelander L: Role of a proximal NF-Y binding promoter element in S Phase-specific expression of mouse ribonucleotide reductase R2 gene. J biol Chem 270:25239–25243 (1995).
20.
Howell ML, Sanders-Loehr J, Loehr TM, Roseman NA, Mathews CK, Slabaugh MB: Cloning of the Vaccinia virus ribonucleotide reductase small subunit gene. J biol Chem 267:1705–1711 (1992).
21.
Hurta RA, Samuel SK, Greenberg AH, Wright JA: Early induction of ribonucleotide reductase gene expression by transforming growth factor β-1 in malignant H-ras transformed cell lines. J biol Chem 266:24097–24100 (1991).
22.
Hurta RA, Wright JA: Alterations in the activity and regulation of mammalian ribonucleotide reductase by chlorambucil, a DNA damaging agent. J biol Chem 267:7066–7071 (1992)
23.
Hurta RAR, Wright JA: Mammalian drug resistant mutants with multiple gene amplification: genes encoding the M1 component of ribonucleotide reductase, the M2 component of ribonucleotide reductase, ornithine decarboxylase, p5-8, the H-subunit of ferritin, and the L-subunit of ferritin. Biochim biophys Acta 1087:165–172 (1990).
24.
Jones C, Zhu F, Dhanwada KR: Analysis of a herpes simplex virus 2 fragment from the open reading frame of the large subunit of ribonucleotide reductase with transcriptional regulatory activity. DNA Cell Biol 12:127–137 (1993).
25.
Lankinen H, Everett R, Cross A, Conner J, Marsden HS: Epitope mapping identifies an exposed loop between the unique amino- and conserved carboxy-domains of the large subunit of herpes simplex virus 1 ribonucleotide reductase. J Gen Virol 74:1871–1877 (1993).
26.
Luo JA, Smith CC, Kulka M, Aurelian L: A truncated protein kinase domain of the large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10) expressed in Escherichia coli. J biol Chem 266:20976–20983 (1991).
27.
Mann GJ, Musgrove EA, Fox RM, Thelander L: Ribonucleotide Reductase M1 subunit in cellular proliferation quiescence and differentiation. Cancer Res 48:5151–5156 (1988).
28.
McClarty GA, Chan AKM, Wright JA: Hydroxyurea-induced conversion of mammalian ribonucleotide reductase to a form hypersensitive to bleomycin. Cancer Res 46:4516–4521 (1986).
29.
Nakano K, Balint E, Ashcroft M, Vousden K: A ribonucleotide reductase gene is a transcriptional target of p53 and p73. Oncogene 19:4283–4289 (2000).
30.
Park JB, Levine M: Characterization of the promoter of the human ribonucleotide reductase R2 gene. Biochem biophys Res Comm 267:651–657 (2000).
31.
Pavloff N, Rivard D, Masson S, Shen SH, Mes-Masson AM: Sequence analysis of the large and small subunits of human ribonucleotide reductase. DNA Seq 2:227–234 (1992).
32.
Salem JS, Scott CP, Li LH, Cooperman BS, Rubin H: High level expression of the large subunit of mouse ribonucleotide reductase in a baculovirus system. FEBS 323:93–95 (1993).
33.
Srinivasan PR, Tonin PN, Wensing EJ, Lewis WH: The gene for ornithine decarboxylase is co-amplified in hydroxyurea-resistant hamster cells. J biol Chem 262:12871–12878 (1987).
34.
Tagger AY, Wright JA: Molecular and cellular characterization of drug resistant hamster cell lines with alternations in ribonucleotide reductase. Int J Cancer 42:760–766 (1988).
35.
Tanaka H, Arakawa H, Yamaguchi T, Shiraishi K, Fukuda S, Matsni K, Takei Y, Nakamura Y: A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage. Nature 404:42–49 (2000).
36.
Thelander L, Berg P: Isolation and characterization of expressible cDNA clones encoding the M1 and M2 subunits of mouse ribonucleotide reductase. Mol Cell Biol 6:3433–3442 (1986).
37.
Thelander M, Graslund A, Thelander L: Subunit M2 of mammalian ribonucleotide reductase. J biol Chem 260:2737–274185 (1985).
38.
Yang-Feng TL, Barton DE, Thelander L, Lewis WH, Srinivasan PR, Francke U: Ribonucleotide reductase M2 subunit sequences mapped to four different chromosomal sites in humans and mice: functional locus identified by its amplification in hydroxyurea-resistant cell lines. Genomics 1:77–86 (1987).
39.
Yen Y, Grill SP, Dutschman GE, Chang CN, Zhou BS, Cheng YC: Characterization of hydroxyurea-resistant human KB cell line with supersensitivity to 6-thioguanine. Cancer Res 54:3686–3691 (1994).
© 2002 S. Karger AG, Basel
2002
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.